tiprankstipranks
Abbisko Cayman Limited (HK:2256)
:2256
Hong Kong Market
2256
Abbisko Cayman Limited
RESEARCH TOOLSreports

Abbisko Cayman Limited (2256) Stock News & Sentiment

6 Followers
Abbisko Grants 290,000 Share Options to Employees Under Post-IPO Scheme
Premium
Company Announcements
Abbisko Grants 290,000 Share Options to Employees Under Post-IPO Scheme
4d ago
2256
Abbisko Wins EMA Orphan Drug Status for Liver Cancer Therapy Irpagratinib
Premium
Company Announcements
Abbisko Wins EMA Orphan Drug Status for Liver Cancer Therapy Irpagratinib
12d ago
2256
Abbisko Wins FDA IND Clearance for Pediatric Achondroplasia Drug ABSK061
Premium
Company Announcements
Abbisko Wins FDA IND Clearance for Pediatric Achondroplasia Drug ABSK061
13d ago
2256
Abbisko Wins FDA Orphan Drug Status for Achondroplasia Candidate ABSK061
Premium
Company Announcements
Abbisko Wins FDA Orphan Drug Status for Achondroplasia Candidate ABSK061
25d ago
2256
Abbisko Starts Phase II Trial of Irpagratinib Combo for Advanced Liver Cancer
Premium
Company Announcements
Abbisko Starts Phase II Trial of Irpagratinib Combo for Advanced Liver Cancer
28d ago
2256
Abbisko Wins FDA Rare Pediatric Disease Status for Achondroplasia Drug ABSK061
Premium
Company Announcements
Abbisko Wins FDA Rare Pediatric Disease Status for Achondroplasia Drug ABSK061
1M ago
2256
Abbisko’s TGCT Drug Pimicotinib Clears Key Global Milestone With Lancet Phase 3 Publication
Premium
Company Announcements
Abbisko’s TGCT Drug Pimicotinib Clears Key Global Milestone With Lancet Phase 3 Publication
1M ago
2256
More HK:2256 News >

2256 News on the Web

Abbisko Grants 290,000 Share Options to Employees Under Post-IPO Scheme
TipRanks News
Neutral
Abbisko Wins EMA Orphan Drug Status for Liver Cancer Therapy Irpagratinib
TipRanks News
Bullish
Abbisko Wins FDA IND Clearance for Pediatric Achondroplasia Drug ABSK061
TipRanks News
Bullish
GF Securities Keeps Their Buy Rating on Abbisko Cayman Limited (2256)
TipRanks News
Bullish
Abbisko Wins FDA Orphan Drug Status for Achondroplasia Candidate ABSK061
TipRanks News
Bullish
Abbisko Starts Phase II Trial of Irpagratinib Combo for Advanced Liver Cancer
TipRanks News
Bullish
Abbisko Cayman Limited (2256) Gets a Buy from UBS
TipRanks News
Bullish
Citi Keeps Their Buy Rating on Abbisko Cayman Limited (2256)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
HK:2256
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:2256’s Media Buzz Sentiment?
1 articles about HK:2256 were published this week. In an average week, 1.25 articles are published.
    What is HK:2256’s weekly average amount of articles?
    In an average week, 1.25 articles about HK:2256 are published.
      What is HK:2256’s News Sentiment?
      50% of articles about HK:2256 were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week